Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.
Cancer Res. 2023 Jan 4;83(1):141-157. doi: 10.1158/0008-5472.CAN-22-0391.
Cancer Res. 2023.
PMID: 36346366
Free PMC article.
Clinical Trial.
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells.
Klotz-Noack K, Klinger B, Rivera M, Bublitz N, Uhlitz F, Riemer P, Lüthen M, Sell T, Kasack K, Gastl B, Ispasanie SSS, Simon T, Janssen N, Schwab M, Zuber J, Horst D, Blüthgen N, Schäfer R, Morkel M, Sers C.
Klotz-Noack K, et al. Among authors: bublitz n.
Cell Rep. 2020 Sep 22;32(12):108184. doi: 10.1016/j.celrep.2020.108184.
Cell Rep. 2020.
PMID: 32966782
Free article.
Item in Clipboard
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe.
Gastl B, Klotz-Noack K, Klinger B, Ispasanie S, Salib KHF, Zuber J, Mamlouk S, Bublitz N, Blüthgen N, Horst D, Morkel M, Schäfer R, Sers C.
Gastl B, et al. Among authors: bublitz n.
Cell Death Dis. 2020 Jul 1;11(7):499. doi: 10.1038/s41419-020-2704-9.
Cell Death Dis. 2020.
PMID: 32612138
Free PMC article.
Item in Clipboard
Cite
Cite